Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

61 trials with published results (16%)

Research Maturity

194 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.5%

24 terminated out of 370 trials

Success Rate

89.0%

+2.4% vs benchmark

Late-Stage Pipeline

24%

89 trials in Phase 3/4

Results Transparency

31%

61 of 194 completed with results

Key Signals

61 with results89% success24 terminated

Data Visualizations

Phase Distribution

297Total
Not Applicable (146)
Early P 1 (5)
P 1 (25)
P 2 (32)
P 3 (46)
P 4 (43)

Trial Status

Completed194
Unknown46
Recruiting46
Not Yet Recruiting31
Terminated24
Active Not Recruiting14

Trial Success Rate

89.0%

Benchmark: 86.6%

Based on 194 completed trials

Clinical Trials (370)

Showing 20 of 20 trials
NCT06212453Phase 2TerminatedPrimary

Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients With Benign Prostatic Hyperplasia-related Obstruction

NCT07306767CompletedPrimary

Ultrasound IPP to Predict Response to Medical Therapy in LUTS/BPH

NCT07526675Not ApplicableRecruiting

Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer

NCT05148156Not ApplicableRecruitingPrimary

Urolift Pre-SBRT for Reduced Urinary Toxicity in Patients With BPH and Prostate Cancer.

NCT07846579Phase 4Not Yet RecruitingPrimary

Ceasing Alpha-blockers Early After Resection of the Prostate (The CLEAR Trial)

NCT07425015Not ApplicableRecruiting

Ambulatory Long Length URodynamics Evaluation

NCT07838077Not Yet Recruiting

Modified SOLTIVE Study

NCT05400980Not ApplicableActive Not RecruitingPrimary

Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath

NCT05757687Not ApplicableActive Not Recruiting

Evaluation of the Safety, Tolerability, and Efficacy of the Omega System for the Treatment of LUTS Due to BPH

NCT04627701Not ApplicableActive Not RecruitingPrimary

Omega Study: Evaluation of the Safety and Efficacy of the Omega System for the Treatment of BPH

NCT06511141Not ApplicableRecruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

NCT07507123Not ApplicableCompletedPrimary

VR Discharge Education After TURP

NCT05898932RecruitingPrimary

Enhanced Clinical Decisions for Management of Benign Prostatic Hyperplasia Using Patient-Reported Outcomes

NCT07777068Not ApplicableCompletedPrimary

Ejaculation-Preserving Versus Conventional Dual Wavelength Diode Laser Vaporization of the Prostate

NCT05567666Not ApplicableCompletedPrimary

Optilume BPH Catheter System in Benign Prostatic Hyperplasia (BPH)

NCT05543200RecruitingPrimary

BPH Global Registry

NCT07745621Not ApplicableNot Yet RecruitingPrimary

Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia

NCT07743060Phase 4Not Yet RecruitingPrimary

Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients

NCT07743034Phase 4Not Yet RecruitingPrimary

Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients

NCT04879940Phase 2Active Not Recruiting

Phase II Study to Evaluate the Safety and Efficacy of Prostatic Artery Embolization

Scroll to load more

Research Network

Activity Timeline